Yiyang Gong

Nanchang, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

Downregulated granzyme M expression: implications for the immune system and prognosis of thyroid cancer.

Downregulated granzyme M expression: implications for the immune system and prognosis of thyroid cancer.

Journal: Gene
Published: November 26, 2024

An immune biomarker associated with EMT serves as a predictor for prognosis and drug response in bladder cancer.

An immune biomarker associated with EMT serves as a predictor for prognosis and drug response in bladder cancer.

Journal: Aging
Published: December 05, 2023

PVALB Was Identified as an Independent Prognostic Factor for HCC Closely Related to Immunity, and Its Absence Accelerates Tumor Progression by Regulating NK Cell Infiltration.

PVALB Was Identified as an Independent Prognostic Factor for HCC Closely Related to Immunity, and Its Absence Accelerates Tumor Progression by Regulating NK Cell Infiltration.

Journal: Journal of hepatocellular carcinoma
Published: November 30, 2023

Identification of a robust biomarker LAPTM4A for glioma based on comprehensive computational biology and experimental verification.

Identification of a robust biomarker LAPTM4A for glioma based on comprehensive computational biology and experimental verification.

Journal: Aging
Published: November 14, 2023

LAMP3 is a potent uterine corpus endometrial carcinoma prognostic biomarker associated with immune behavior.

LAMP3 is a potent uterine corpus endometrial carcinoma prognostic biomarker associated with immune behavior.

Journal: Aging
Published: August 20, 2023

Identified RP2 as a prognostic biomarker for glioma, facilitating glioma pathogenesis mainly via regulating tumor immunity.

Identified RP2 as a prognostic biomarker for glioma, facilitating glioma pathogenesis mainly via regulating tumor immunity.

Journal: Aging
Published: April 03, 2023

Biological function analysis of ARHGAP39 as an independent prognostic biomarker in hepatocellular carcinoma.

Biological function analysis of ARHGAP39 as an independent prognostic biomarker in hepatocellular carcinoma.

Journal: Aging
Published: January 01, 2023

FARSB serves as a novel hypomethylated and immune cell infiltration related prognostic biomarker in hepatocellular carcinoma.

FARSB serves as a novel hypomethylated and immune cell infiltration related prognostic biomarker in hepatocellular carcinoma.

Journal: Aging
Published: December 28, 2022

Comprehensive analysis reveals TSEN54 as a robust prognosis biomarker and promising immune-related therapeutic target for hepatocellular carcinoma.

Comprehensive analysis reveals TSEN54 as a robust prognosis biomarker and promising immune-related therapeutic target for hepatocellular carcinoma.

Journal: Aging
Published: December 16, 2022

ZNF765 is a prognostic biomarker of hepatocellular carcinoma associated with cell cycle, immune infiltration, m6A modification, and drug susceptibility.

ZNF765 is a prognostic biomarker of hepatocellular carcinoma associated with cell cycle, immune infiltration, m6A modification, and drug susceptibility.

Journal: Aging
Published: September 21, 2022

Identification of KRBA1 as a Potential Prognostic Biomarker Associated with Immune Infiltration and m6A Modification in Hepatocellular Carcinoma.

Identification of KRBA1 as a Potential Prognostic Biomarker Associated with Immune Infiltration and m6A Modification in Hepatocellular Carcinoma.

Journal: Journal of hepatocellular carcinoma
Published: March 15, 2022

MND1 functions as a potential prognostic biomarker associated with cell cycle and immune infiltration in kidney renal clear cell carcinoma.

MND1 functions as a potential prognostic biomarker associated with cell cycle and immune infiltration in kidney renal clear cell carcinoma.

Journal: Aging
Published: November 30, 2021
Showing 1-12 of 12

Last Updated: 09/26/2026